2020
DOI: 10.1007/s00213-020-05580-2
|View full text |Cite|
|
Sign up to set email alerts
|

17β-Estradiol augments the neuroprotective effect of agomelatine in depressive- and anxiety-like behaviors in ovariectomized rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(10 citation statements)
references
References 63 publications
0
9
0
Order By: Relevance
“…After ovariectomy, the mRNA expression of ERα and ERβ in the hippocampus of OVX rats decreased with a progressive decrease in estrogen levels (El-Khatib et al, 2020). Some studies have shown that improvement in depression-like behavior in OVX rats is partly attributed to the increased serum E2 levels after exercise (Lu et al, 2014), whereas several studies have reported no increase in plasma or serum estrogen levels in OVX rats after exercise (Choi et al, 2005;Rauf et al, 2015;He et al, 2021).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…After ovariectomy, the mRNA expression of ERα and ERβ in the hippocampus of OVX rats decreased with a progressive decrease in estrogen levels (El-Khatib et al, 2020). Some studies have shown that improvement in depression-like behavior in OVX rats is partly attributed to the increased serum E2 levels after exercise (Lu et al, 2014), whereas several studies have reported no increase in plasma or serum estrogen levels in OVX rats after exercise (Choi et al, 2005;Rauf et al, 2015;He et al, 2021).…”
Section: Discussionmentioning
confidence: 99%
“…Treatment with 17β-estradiol for 4 weeks can alleviate anxiety-like behaviors (Renczés et al, 2020), attenuate stress-induced exploratory and anxiety-like behavioral impairment and improve spatial cognition and memory deficits in ovariectomized (OVX) rats (Khaleghi et al, 2021). In addition, exogenous estrogen supplementation can improve anxiety-depression-like behavioral manifestations in OVX rats (Xu et al, 2016;Estrada et al, 2018;El-Khatib et al, 2020) and those with post-stroke depression (Jiang et al, 2021). The antidepressant effect of estrogen is mainly exerted by estrogen receptor (Walf et al, 2009;Furuta et al, 2013;Carrier et al, 2015).…”
Section: Introductionmentioning
confidence: 99%
“…On the other hand, it has been suggested that the use of a combined therapy, estradiol plus antidepressant, could be advantageous for the treatment of depression in perimenopausal or menopausal women (Vega-Rivera et al, 2016). Some clinical studies suggest that estrogen may enhance the effect of other antidepressants (Estrada-Camarena et al, 2004), such as selective serotonin reuptake inhibitors (SSRIs) (Benmansour et al, 2016b), agomelatine (El-Khatib et al, 2020), escitalopram (Ibrahim et al, 2016), fluoxetine (Récamier-Carballo et al, 2012), and topiramate (Molina-Hernández et al, 2014). However, other studies have reported that estradiol can block the antidepressant effect of some antidepressants such as sertraline, desipramine, or fluvoxamine (Shah and Frazer, 2014;Benmansour et al, 2016aBenmansour et al, , 2016b.…”
Section: Introductionmentioning
confidence: 99%
“…Increasing evidences show that BDNF exerts an antidepressive effect mainly by promoting neuronal proliferation ( 25 ). The decreased level of hippocampal BDNF in a rat model of depression was found to inhibit neuronal proliferation ( 26 ). Moreover, central inflammation was associated with reduced BDNF, as confirmed by the series of studies on animals and humans ( 27 , 28 ).…”
Section: Introductionmentioning
confidence: 99%